ArticleFrontiers in oncology2026

Integrated CDK4/6 inhibitor resistance and primary-metastatic discordance in hormone receptor-positive/HER2-negative metastatic breast cancer: a translational framework focused on invasive ductal carcinoma with gastric metastasis.

Minyi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.